Huazheng Dong1, Wenyang Huang2, Xiaodong Ji3, Shuang Xia3, Zhiwei Shen4, Dehui Zou2, Wen Shen3, and Zhiyi Song1
1Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China, Tianjin, China, 2State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Tianjin 300020, China, Tianjin, China, 3Tianjin First Central Hospital Affiliated To Nankai University, Tianjin, China, Tianjin, China, 4Philips healthcare，Beijing， China, Beijing, China
1Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China, Tianjin, China, 2State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Tianjin 300020, China, Tianjin, China, 3Tianjin First Central Hospital Affiliated To Nankai University, Tianjin, China, Tianjin, China, 4Philips healthcare，Beijing， China, Beijing, China
For newly diagnosed MM patients, we aim to evaluate the efficacy prediction of early treatment response in MM patients with and without anemia based on the WB-MRI. We found that early treatment response of MM could be predicted in patients without anemia using TBS, ADC and sFF
Comparison of baseline MR parameters
between the two response groups
Spearman correlation analysis between
response depth and MRI parameters